Marathon Pharmaceuticals is an established provider of medications in the United States. The company has its locations in New Jersey, Northbrook, Chicago and Illinois where it conducts its operations of working with patients and clients who suffer from rare and complicated illnesses. The firm also targets people who have unmet medical needs.
Unlike other medical companies that specialize in manufacturing medicines that are easy to produce, large-scale medications and drugs, Marathon Pharmaceuticals focuses on the small-scale production of hard to manufacture drugs that solve the needs of the people who have rare diseases. The company understands that patients with rare diseases have few treatment choices and some even lack any and chooses to recognize all the needs of such patients.
Recently, Marathon Pharmaceuticals publicized the launching of its Bioscience Center. The Marathon Bioscience Center is aimed to serve as the central production site for the medications and drugs for cancer treatment, central nervous system therapies, gastrointestinal diseases, movement disorders, endocrine deficiencies, and other critical illnesses. The Bioscience Center has been supplied with staff members who have extensive experience and expertise. The attendants of the Marathon Bioscience Center have experiences in clinical, research and regulatory fields. They use their professionalism to offer unmatched services and products to the clients.
Marathon Pharmaceuticals has received a reputation for its ability of manufacturing high-need medicine products for the people who have rare diseases that have few treatment options. It has overseen the manufacturing and production of various products that are very effective in conquering a variety of the unique conditions that affect its clients. Some of the high-need medications produced by Marathon Pharmaceuticals include Amytal Sodium, ZiNGO, Opium Tincture, PEPCID, and Seconal Sodium. Seconal Sodium and Amytal Sodium are both barbiturate medication products. The two medications are used as nonselective depressants for the medical challenges that affect the central nervous system. Their effects are responsible for depressing the sensory cortex which in return reduces the motor activity.
The nonselective depressants of the central nervous system cause an effect that is helpful for the treatment of patients who need drowsiness, hypnosis, and sedation. Such patients suffer from insomnia and others are the ones that require a pre-anesthetic before undergoing a surgical procedure.